Bufferin and blood lactate dehydrogenase increased Patient Reports February 12, 2012

Bufferin Side Effects Report #5712536-1
Bufferin side effect was reported by a Consumer or non-health professional from JAPAN on Apr 10, 2008. Male patient, 40 years of age, was diagnosed with polycythaemia and was treated with Bufferin. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood potassium increased, compartment syndrome, erythema, muscle haemorrhage, muscle necrosis, muscle swelling, pain in extremity. Bufferin dosage: 81 MG, QD, ORAL. During the same period patient was treated with KELNAC PLAUNOTOL). Patient was hospitalized. Patient recovered.

Bufferin Side Effects Report #5228270-0
Bufferin side effect was reported by a Physician from JAPAN on Jan 24, 2007. Male patient, 77 years of age, weighting 141.1 lb, was diagnosed with acute myocardial infarction, gastric ulcer, diabetes mellitus, hypertension and was treated with Bufferin. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood glucose increased, blood lactate dehydrogenase increased, c-reactive protein increased, catheterisation cardiac, chest x-ray abnormal, cough, haematocrit decreased, haemoglobin decreased. Bufferin dosage: 162 MG/DAY. During the same period patient was treated with PANALDINE, OMEPRAL, EUGLUCON, DIOVAN, RENIVACE. Patient was hospitalized. Patient recovered.

Bufferin Side Effects Report #5181080-5
Bufferin side effect was reported by a Physician from JAPAN on Nov 21, 2006. Male patient, 77 years of age, weighting 141.1 lb, was diagnosed with acute myocardial infarction, gastric ulcer, diabetes mellitus, hypertension and was treated with Bufferin. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood glucose increased, blood lactate dehydrogenase increased, c-reactive protein increased, catheterisation cardiac, chest x-ray abnormal, cough, haematocrit decreased, haemoglobin decreased. Bufferin dosage: 162 MG/DAY. During the same period patient was treated with PANALDINE, OMEPRAL, EUGLUCON, DIOVAN, RENIVACE. Patient was hospitalized. Patient recovered.

Bufferin Side Effects Report #5194700-6
Bufferin side effect was reported by a Physician from JAPAN on Nov 21, 2006. Male patient, 77 years of age, weighting 141.1 lb, was diagnosed with acute myocardial infarction, gastric ulcer, diabetes mellitus, hypertension and was treated with Bufferin. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood glucose increased, blood lactate dehydrogenase increased, c-reactive protein increased, catheterisation cardiac, chest x-ray abnormal, cough, haematocrit decreased, haemoglobin decreased. Bufferin dosage: 162 MG/DAY. During the same period patient was treated with PANALDINE, OMEPRAL, EUGLUCON, DIOVAN, RENIVACE. Patient was hospitalized. Patient recovered.


Bufferin Side Effects Report #5264699-2
Bufferin side effect was reported by a Consumer or non-health professional from JAPAN on Mar 06, 2007. Female patient, 26 years of age, weighting 119.0 lb, was diagnosed with systemic lupus erythematosus, lupus nephritis and was treated with Bufferin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood fibrinogen increased, blood lactate dehydrogenase increased, brain natriuretic peptide increased, cardiac failure congestive, cardiac murmur, dilatation ventricular. Bufferin dosage: 81 MG/D. During the same period patient was treated with ONEALFA, LASIX, ZANTAC, SELBEX, PREDNISOLONE, NEORAL. Patient was hospitalized. Patient recovered.